Factors influencing the natural history of colorectal liver metastases

医学 自然史 单变量分析 恶性肿瘤 结直肠癌 内科学 多元分析 疾病 预后变量 淋巴结 外科 胃肠病学 肿瘤科 癌症
作者
R. Stangl,A. Altendorf-Hofmann,RM Charnley,J. Scheele
出处
期刊:The Lancet [Elsevier BV]
卷期号:343 (8910): 1405-1410 被引量:672
标识
DOI:10.1016/s0140-6736(94)92529-1
摘要

Palliative treatment of unresectable colorectal liver metastases is common and often justified with reference to historical data on the natural history of the disease. However, in view of the improved diagnostic accuracy of modern imaging techniques, these previously published series do not provide sufficient guidance to judge the prognostic efficacy of palliative treatment. In the late 1970s we started prospectively to collect data on consecutive patients with colorectal liver metastases according to a standard protocol. We now present data derived from this series on factors that may affect outcome in untreated patients. Between January, 1980, and December, 1990, 1099 consecutive patients were recorded, of whom 566 (51.5%) received no treatment for their hepatic tumour. Excluding 34 early deaths and 48 patients with a second malignant tumour, 484 patients provided the basis for analysis. All patients were followed up to July 1, 1993, or death. At the closing date of the study only 1 untreated patient was still alive. The impact of various factors on survival was analysed by univariate and multivariate analyses. Six independent determinants of survival were identified in the following order: percentage liver volume replaced by tumour (LVRT), grade of malignancy of the primary tumour, presence of extrahepatic disease, mesenteric lymph-node involvement, serum carcino-embryonic antigen, and age. The subsequent combination of the independently significant factors, separately for patients with up to or more than 25% LVRT, yielded a prognostic tree that displayed median survival times of various subgroups of 3.8 to 21.3 months. These findings provide a framework to estimate the survival expectancy of untreated patients, thereby allowing improved assessment of the prognostic significance of palliative therapeutic approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CNS完成签到,获得积分10
1秒前
殷志远完成签到,获得积分20
2秒前
mengmenglv完成签到 ,获得积分0
2秒前
多乐多滋完成签到,获得积分10
2秒前
叶95完成签到 ,获得积分10
4秒前
uil发布了新的文献求助10
5秒前
隐形的非笑完成签到 ,获得积分10
6秒前
sui完成签到,获得积分10
8秒前
lulu完成签到 ,获得积分10
9秒前
沙力VAN完成签到,获得积分10
10秒前
完美砖家完成签到,获得积分10
10秒前
XTechMan完成签到,获得积分10
11秒前
科研通AI6应助无限冷之采纳,获得10
11秒前
wuli猴猴完成签到 ,获得积分10
11秒前
14秒前
生化小卜完成签到,获得积分10
14秒前
uil完成签到,获得积分10
14秒前
Parrot_PAI完成签到,获得积分10
15秒前
窗窗窗雨完成签到,获得积分10
15秒前
迅速的宛海完成签到 ,获得积分10
15秒前
18秒前
蜡笔小鱼完成签到,获得积分10
18秒前
20秒前
21秒前
yinhe完成签到 ,获得积分10
21秒前
22秒前
萝卜猪完成签到,获得积分10
22秒前
ajjdnd完成签到 ,获得积分10
24秒前
科研混子发布了新的文献求助10
24秒前
Y123456完成签到,获得积分10
24秒前
25秒前
ESC惠子子子子子完成签到 ,获得积分10
25秒前
25秒前
只道寻常完成签到,获得积分10
26秒前
yemiao完成签到,获得积分10
27秒前
长安完成签到,获得积分20
27秒前
28秒前
勤劳宛菡完成签到 ,获得积分10
28秒前
张张发布了新的文献求助10
28秒前
msk完成签到 ,获得积分10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
Nach dem Geist? 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
Optimisation de cristallisation en solution de deux composés organiques en vue de leur purification 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5044838
求助须知:如何正确求助?哪些是违规求助? 4274315
关于积分的说明 13323674
捐赠科研通 4088088
什么是DOI,文献DOI怎么找? 2236731
邀请新用户注册赠送积分活动 1244114
关于科研通互助平台的介绍 1172128